Day: April 21, 2025
ST. JOHN’S, Newfoundland and Labrador, April 21, 2025 (GLOBE NEWSWIRE) — Kraken Robotics Inc. (“Kraken” or the “Company”) (TSX-V: PNG, OTCQB: KRKNF) announces that it will release fiscal year 2024 financial results at 6:30am ET on Monday, April 28, 2025. The Company has also scheduled a webcast to discuss results on Monday, April 28, 2025 at 8:30am ET.
The webcast will be hosted by Greg Reid, President and CEO and Joe Mackay, CFO of Kraken Robotics and will cover fourth quarter and full year 2024 results ending December 31, 2024.
Webcast Details:Date: Monday, April 28, 2025
Time: 8:30am ET
URL: https://event.choruscall.com/mediaframe/webcast.html?webcastid=ktSbjyD1A recording of the webcast and supporting materials will be made available in the investor’s section of the Company’s website at https://www.krakenrobotics.com/investors.Figure...
Alumis and ACELYRIN Announce Amended Merger Agreement
Written by Customer Service on . Posted in Mergers And Acquisitions.
ACELYRIN stockholders to receive increased ownership in the combined company through revised exchange ratio; Alumis and ACELYRIN stockholders to now own approximately 52% and 48%, respectively, of the combined company on a fully diluted basis
Merger maximizes the potential value for ACELYRIN stockholders and creates a stronger combined company, best-positioned to realize long-term value of multiple late-stage assets
ACELYRIN files investor presentation highlighting benefits of proposed merger and comprehensive Board process
Special Meeting of Stockholders for both companies to be held May 13, 2025
SOUTH SAN FRANCISCO, Calif. and LOS ANGELES, April 21, 2025 (GLOBE NEWSWIRE) — Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing therapies using a precision approach to optimize clinical outcomes and...
Alumis and ACELYRIN Announce Amended Merger Agreement
Written by Customer Service on . Posted in Mergers And Acquisitions.
ACELYRIN stockholders to receive increased ownership in the combined company through revised exchange ratio; Alumis and ACELYRIN stockholders to now own approximately 52% and 48%, respectively, of the combined company on a fully diluted basis
Merger maximizes the potential value for ACELYRIN stockholders and creates a stronger combined company, best-positioned to realize long-term value of multiple late-stage assets
ACELYRIN files investor presentation highlighting benefits of proposed merger and comprehensive Board process
Special Meeting of Stockholders for both companies to be held May 13, 2025
SOUTH SAN FRANCISCO, Calif. and LOS ANGELES, April 21, 2025 (GLOBE NEWSWIRE) — Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing therapies using a precision approach to optimize clinical outcomes and...
Blue Moon Metals Appoints Boi Linh Doig as Vice-President, Mining
Written by Customer Service on . Posted in Public Companies.
TORONTO, April 21, 2025 (GLOBE NEWSWIRE) — Blue Moon Metals Inc. (“Blue Moon” or the “Company”) (TSXV: MOON; OTCQX: BMOOF), is pleased to announce the appointment of Boi Linh Doig as Vice-President, Mining, as it continues to build out its management team to support the Company’s continued growth in the development of its three polymetallic brownfield projects.
“We are delighted to welcome Boi Linh to our team,” said Christian Kargl-Simard, CEO of Blue Moon. “With her solid experience in underground mining within the challenging Red Lake Gold Camp over the last 20 years, she brings extensive expertise in both operational leadership and strategic mine planning and will be pivotal in the advancement of all three underground development projects.”
Mrs. Doig has over 20 years of underground experience in the mining industry....
Castellum, Inc. Reduces Principal Balance by $2 Million on Notes Payable to Robert Eisiminger and Extends Maturity Date
Written by Customer Service on . Posted in Public Companies.
Castellum, Inc. Reduces Principal Balance by $2 Million on Notes PayableCastellum, Inc. (NYSE-American: CTM) (“Castellum” or “CTM”) entered into an amendment to a letter agreement to, among other things, reduce the principal balance on two notes payable to Robert Eisiminger by $2 Million, leaving an aggregate principal balance owed of $4 million – https://castellumus.com/VIENNA, Va., April 21, 2025 (GLOBE NEWSWIRE) — Castellum, Inc. (NYSE-American: CTM) (“Castellum” or “CTM”), a cybersecurity, electronic warfare, and software engineering services company focused on the federal government, announces that it has entered into an amendment to a letter agreement to, among other things, reduce the principal balance on two notes payable to Robert Eisiminger by $2 Million, leaving an aggregate principal...
Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis
Written by Customer Service on . Posted in Public Companies.
Independent Cost-Effectiveness Analysis Concludes Nociscan is Effective and Less Costly Compared to Provocative Discography
Conclusions Illustrate Nociscan Saves $1,712 per Patient and Improves Surgical Success by 10%BROOMFIELD, Colo., April 21, 2025 (GLOBE NEWSWIRE) — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today the publication of a peer-reviewed article in Clinicoeconomics and Outcomes Research titled “The Comparison of Cost-Effectiveness Between Magnetic Resonance Spectroscopy and Provocative Discography in the Identification of Chronic Low Back Pain Surgery Candidates.”
“Chronic low back pain is...
Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, April 21, 2025 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that Sabeen Mekan, M.D., has been appointed as Senior Vice President, Clinical Development. Reporting directly to the Chief Executive Officer, Dr. Mekan will have a key role in formulating the clinical development strategy for Zymeworks’ clinical-stage oncology portfolio, including global regulatory affairs. Dr. Jeff Smith, who joined Zymeworks in 2023, will continue as Executive Vice President & Chief Medical Officer, with primary responsibility for Zymeworks’ emerging R&D portfolio...
Jeffs’ Brands: Fort Submits Android Version of AI-Based Pest Control App to Google Play
Written by Customer Service on . Posted in Public Companies.
Tel Aviv, Israel, April 21, 2025 (GLOBE NEWSWIRE) — Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, announced today that its wholly-owned subsidiary, Fort Products Limited (“Fort”), has submitted the Android version of its artificial intelligence (AI)-powered pest control mobile application for review on Google Play. This follows the successful completion of the development and internal testing of the mobile app, marking a major milestone as Fort transitions from internal validation towards commercial rollout.
The application harnesses AI to help users identify pests and recommends tailored treatments based on species, infestation severity, and user preferences. It also features curated product suggestions, including Fort’s...
Niu Technologies to Report First Quarter 2025 Financial Results on May 19, 2025
Written by Customer Service on . Posted in Public Companies.
BEIJING, April 21, 2025 (GLOBE NEWSWIRE) — Niu Technologies (“NIU” or “the Company”) (NASDAQ: NIU), the world’s leading provider of smart urban mobility solutions, today announced that it will report its financial results for the first quarter 2025 before the U.S. market opens on Monday, May 19, 2025.
The corporate presentation and financial spreadsheets will be posted on NIU’s investor relations website at:https://ir.niu.com/financial-information/quarterly-results
The Company will host an earnings conference call on Monday, May 19, 2025 at 8:00 AM U.S. Eastern Time (8:00 PM Beijing/Hong Kong Time) to discuss the financial and business results.
To join via phone, participants need to register in advance of the conference call using the link provided below. Upon registration, participants will receive dial-in numbers and a personal...
Change to Financial Calendar: New Publication Date for Annual Report.
Written by Customer Service on . Posted in Public Companies.
April 21st, 2025
Change to Financial Calendar: New Publication Date for Annual Report.
Roskilde, 21st April – Photocat A/S announces a revision to its financial calendar regarding the publication of the Annual Report for the financial year 2024.
Previously, the financial calendar indicated a publication date of 23 April 2025. This date was published in error and had not been confirmed with the company’s auditors. The Annual Report will instead be published on 6 May 2025, which is in accordance with the company’s Articles of Association and consistent with previous years’ reporting timelines.
We regret any inconvenience this may have caused and appreciate the understanding of our shareholders and stakeholders.
For more information, please contact:Michael HumlePhotocat A/STel: +45 7022 5055Email: ka@photocat.net
About Photocat:Photocat...